Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Opioid receptor antagonist reducing opioid induced respiratory depression More
Treatment of movement disorders associated with organic central nervous system conditions, e.g. Huntington's chorea, hemiballismus and senile chorea. More
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola. More
MRI contast medium More
Zolmitripan Oral Dispersible Film (ODF) is a a novel, non-mucoadhesive, fast dissolving oral dosage form of Zolmitriptan More
Collagen-based biodegradable matrices for localized drug delivery More
Next Generation Botulinum Toxin Preparation More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2010 - 510 pages - $2,695
Oct 2010 - 53 pages - $1,000
Jun 2006 - 1068 pages - $2,495
Mar 2011 - 107 pages - $3,500
Jan 2010 - $75
Jan 2011 - 80 pages - $1,500
Sep 2011 - 97 pages - $3,500
Feb 2011 - 75 pages - $1,000
Aug 2011 - 87 pages - $1,500
Apr 2011 - 89 pages - $1,500
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us